期刊文献+

淀粉样心肌病的诊断 被引量:1

The diagnostic approach to amyloid cardiomyopathy
下载PDF
导出
摘要 目的探讨淀粉样心肌病的诊断方法。方法分析2例表现为难治性右心衰竭患者,分别采用右心导管和心内膜活检等方法明确诊断。结果 2例患者心脏超声和MRI均提示室间隔增厚、心肌回声和延迟扫描增强,右心导管检查提示右心压力增高,心内膜活检刚果红染色阳性。结论心脏症状通常是系统性淀粉样变性的第一表现,部分患者表现为难治性心力衰竭,右心导管和心内膜活检可以明确诊断。 Objective To investigate the diagnostic approach to amyloid cardiomyopathy. Methods The clinical data of two patients with amyloid cardiomyopathy, which presented clinically as refractory right heart failure, were retrospectively analyzed. The diagnosis of both patients was confirmed by means of right heart catheterization and endomyocardial biopsy. Results Thickened ventricular septum was demonstrated on echocardiograph and delayed myocardial enhancement was seen on enhanced MRI in both patients. Right heart catheterization examination revealed a higher right heart pressure, and endomyocardial biopsy showed that Congo red staining was positive. Conclusion Usually, cardiac symptom is the first manifestation in systemic amyloidosis. In some patients the disease is manifested as refractory heart failure. Right heart catheterization and endomyocardial biopsy can confirm the diagnosis.(J Intervent Radiol, 2012, 21: 766-769)
出处 《介入放射学杂志》 CSCD 北大核心 2012年第9期766-769,共4页 Journal of Interventional Radiology
基金 上海交通大学医公交叉重点项目(YG2011ZD02)
关键词 淀粉样心肌病 淀粉样蛋白 心内膜活检 amyloid cardiomyopathy amyloid endomyocardial biopsy
  • 相关文献

参考文献19

  • 1Merlini G, Bellotti V. Molecular mechanisms of amyloidosis [J].N Engl J Med, 2003,349: 583 -596.
  • 2Garca - Pava P, Avellana P, Bomstein B, et al. Familialapproach in hereditary transthyretin cardiac amyloidosis [J].RevEsp Cardiol, 2011, 64: 523 -526.
  • 3Rapezzi C,Merlini G,Quarta CC, et al. Systemic cardiacamyloidoses : disease profiles and clinical courses of the 3 maintypes[J].Circulation, 2009,120: 1203 - 1212.
  • 4Bradshaw SH, Veinot JP. Cardiac amyloidosis: what are theindications for transplant? [J].Curr Opin Cardiol, 2012,27:143 - 147.
  • 5Garcia-Pavia P, Tome-Esteban MT, Rapezzi C.Amyloidosis. Alsoa heart disease[J].Rev Esp Cardiol, 2011,64: 797 - 808.
  • 6Selvanayagam JB, Hawkins PN, Paul B, et al. Evaluation andmanagement of the cardiac amyloidosis [J].J Am Coll Cardiol,2007,50: 2101 -2110.
  • 7Rahman JE, Helou EF, Gelzer - Bell R, et al. Noninvasivediagnosis of biopsy - proven cardiac amyloidosis [J].J Am CollCardiol, 2004,43: 410 -415.
  • 8Koyama J, Ray - Sequin PA, Falk RH. Longitudinal myocardialfunction assessed by tissue velocity, strain, and strain ratetissue Doppler echocardiography in patients with AL (primary)cardiac amyloidosis[j].Circulation, 2003,107: 2446 ? 2452.
  • 9Ogiwara F, Koyama J, Ikeda S, et al. Comparison of the strainDoppler echocardiographic features of familial amyloidpolyneuropathy (FAP) and light - chain amyloidosis [J].Am JCardiol, 2005,95: 538 -540.
  • 10Murtagh B,Hammill SC, Gertz MA, et al. Electrocardiographicfindings in primary systemic amyloidosis and biopsy provencardiac involvement[J].Am J Cardiol, 2005,95: 535 -537.

二级参考文献2

  • 1Veinot JP. Diagnostic endomyocardial biopsy: secondary myocardial diseases and other clinical indications. Can J Cardiol, 2002,18: 287-296.
  • 2Pepys MB. Pathogenesis, diagnosis and treatment of systemic amyloidosis. Philos Trans R Soc Lond Biol Sci, 2001,356 : 203-210.

同被引文献12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部